Bernard Lown, cardiologist who co-founded antiwar group that won Nobel Peace Prize, dies
Dr. Bernard Lown, the cardiologist who invented the first reliable heart defibrillator and later co-founded an anti-nuclear war group that was awarded a Nobel Peace Prize, died Tuesday. He was 99.
The Boston Globe reported that the Lithuania-born doctor’s health had been declining from congestive heart failure and that he died at his Boston-area home.
Lown, who was a professor at Harvard University and a physician at Brigham and Women’s Hospital in Boston, had helped advance cardiac treatment.
He’d been among the first doctors to emphasize the importance of diet and exercise in treating heart disease and introduced the drug lidocaine as a treatment for arrhythmia. In 1962, Lown invented the direct-current defibrillator, or cardioverter, which uses electric shocks to get hearts to resume beating.
He was also an outspoken social activist, founding Physicians for Social Responsibility in 1960 and later co-founding International Physicians for the Prevention of Nuclear War in the 1980s.
The international antiwar group called for a moratorium on testing and building nuclear weapons. It was awarded the 1985 Nobel Peace Prize for raising awareness about the consequences of nuclear war during the height of Cold War tensions between the U.S. and the Soviet Union.
At its peak, the group had more than 200,000 members and chapters in more than 60 countries.
“To me, you cannot be committed to health without being engaged in social struggle for health,” Lown told the Globe in 2001.
Lown was born in Utena, Lithuania, in 1921 and moved in 1935 with his father, a rabbi, to Lewiston, Maine, where a bridge now bears his name. He graduated from the University of Maine and received his medical degree from Johns Hopkins University in Maryland.
Survivors include his three children and a number of grandchildren.
Must-read stories from the L.A. Times
Get all the day's most vital news with our Today's Headlines newsletter, sent every weekday morning.
You may occasionally receive promotional content from the Los Angeles Times.